01 1Apotheca Company
01 1Sarcolacticum acidum
01 1U.S.A
NDC Package Code : 57520-1262
Start Marketing Date : 2014-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (3g)
Marketing Category : DRUG FOR FURTHER PROCESSING
22
PharmaCompass offers a list of L-Lactic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right L-Lactic Acid manufacturer or L-Lactic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L-Lactic Acid manufacturer or L-Lactic Acid supplier.
PharmaCompass also assists you with knowing the L-Lactic Acid API Price utilized in the formulation of products. L-Lactic Acid API Price is not always fixed or binding as the L-Lactic Acid Price is obtained through a variety of data sources. The L-Lactic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Atrisorb manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atrisorb, including repackagers and relabelers. The FDA regulates Atrisorb manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atrisorb API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Atrisorb supplier is an individual or a company that provides Atrisorb active pharmaceutical ingredient (API) or Atrisorb finished formulations upon request. The Atrisorb suppliers may include Atrisorb API manufacturers, exporters, distributors and traders.
click here to find a list of Atrisorb suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Atrisorb as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Atrisorb API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Atrisorb as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Atrisorb and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Atrisorb NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Atrisorb suppliers with NDC on PharmaCompass.
